Hematology Biobank : Invitro Study of Blood Disorders

Recruiting

• Conditions: Hematological Disorders

• Registration Number: NCT02442011
• Lead Sponsor: Albert Einstein College of Medicine

Brief Summary

This is a bio repository of blood specimens from subjects with different Hematological disorders.

Detailed Description

There has been a marked increase in our knowledge of Blood Disorders in the last decade. Much of this knowledge comes from examining blood specimens from patients and subjecting these samples to red cell, plasma, serum or DNA analyses. We propose to set up a Hematology biobank, which will include patient histories, their medical progress and a linked but de-identified bank of blood samples. This will enable us to have a large database, which can be used to learn more about these diseases.

The Hematology biobank will use whole blood, red blood cells, plasma, serum and/or DNA.

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2015-05-07
• Study First Submitted QC: 2015-05-08
• Study First Posted: 2015-05-13
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-19
• Last Update Posted: 2024-12-20
• Primary Completion: 2030-01
• Study Completion: 2030-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Above 18 years of age and able to consent

Exclusion Criteria

None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biobank	5 years	To have specimens available for IRB approved studies

Trial Locations

Locations (1)

Montefiore Medical Center; 🇺🇸 Bronx, New York, United States